Valuation: Sight Sciences, Inc.

Market Cap 449M 384M 359M 329M 618M 42.96B 631M 4.25B 1.66B 21.53B 1.69B 1.65B 71.28B P/E 2026 *
-14x
P/E 2027 * -17.5x
Enterprise Value 411M 352M 329M 301M 566M 39.35B 578M 3.9B 1.52B 19.72B 1.54B 1.51B 65.29B EV / Sales 2026 *
4.55x
EV / Sales 2027 * 4.17x
Free-Float
80.27%
Yield 2026 *
-
Yield 2027 * -
1 day-3.78%
1 week-2.04%
Current month+54.94%
1 month+61.71%
3 months+67.70%
6 months+50.93%
Current year+2.77%
1 week 7.89
Extreme 7.89
8.85
1 month 4.41
Extreme 4.41
8.85
Current year 3.38
Extreme 3.378
8.85
1 year 3.19
Extreme 3.19
9.24
3 years 1.04
Extreme 1.04
9.24
5 years 1.04
Extreme 1.04
38.72
10 years 1.04
Extreme 1.04
42.57
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 56 2009-12-31
Chief Executive Officer 51 2009-12-31
Director of Finance/CFO 43 2025-11-04
Director TitleAgeSince
Director/Board Member 51 2009-12-31
Director/Board Member 56 2009-12-31
Chairman 74 2016-12-31
Date Insider Type Main position Quantity % Market Cap.
8/10/26 Free

General Counsel

181,818 0.3342%
7/6/26 Sell

Founder

-7,418 0.0136%
7/6/26 Sell

General Counsel

-12,733 0.0234%
Change 5-day change 1-year change 3-year change Capi.($)
-3.78%-2.04%+100.25%+11.64% 449M
-0.25%+2.58%-13.82%+10.06% 198B
-1.94%+1.90%-0.99%+13.22% 118B
-0.76%+1.51%+3.62%+74.44% 60.05B
-1.37%-6.57%+28.86%+58.31% 53.18B
+0.01%+3.10%-5.81%-31.45% 51.11B
+0.38%-1.38%+10.47%-14.93% 34.05B
-3.92%-8.43% - - 28.58B
+0.28%+2.20%+43.59%-8.77% 24.9B
-0.49%-0.14%-5.53%+5.30% 22.98B
Average -0.94%-0.54%+17.85%+13.09% 59.09B
Weighted average by Cap. -0.35%+0.83%-0.06%+15.85%

Financials

2026 *2027 *
Net sales 90.35M 77.36M 72.18M 66.23M 124M 8.65B 127M 856M 334M 4.33B 339M 332M 14.34B 101M 86.53M 80.74M 74.08M 139M 9.67B 142M 958M 373M 4.85B 379M 371M 16.04B
Net income -33.35M -28.55M -26.64M -24.45M -45.94M -3.19B -46.84M -316M -123M -1.6B -125M -122M -5.29B -28.58M -24.47M -22.83M -20.95M -39.37M -2.73B -40.14M -271M -106M -1.37B -107M -105M -4.54B
Net Debt -37.73M -32.31M -30.14M -27.66M -51.97M -3.61B -52.99M -358M -139M -1.81B -142M -139M -5.99B -27.73M -23.74M -22.15M -20.33M -38.2M -2.65B -38.95M -263M -102M -1.33B -104M -102M -4.4B
Logo Sight Sciences, Inc.
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Employees
186
Date Price Change Volume
26-08-20 US$8.150 -3.78% 162,760
26-08-19 US$8.470 +3.04% 465,131
26-08-18 US$8.220 -0.24% 300,452
26-08-17 US$8.240 +1.23% 471,745
26-08-14 US$8.140 -2.16% 332,025
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
8.150USD
Average target price
9.000USD
Spread / Average Target
+10.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SGHT Stock